Endowed Chairs make effective use of donations received from the private sector, etc. to promote and enhance education and research at the university. In doing so, the goal is to go about ensuring speedy responses to the requirements of society and changes in conditions when it comes to the realm of academics, and at the same time contribute to the diversification of education and research frameworks.
Evidence-based medical care is important for providing better medical care. However, in actual clinical practice, there is not always a lot of evidence that guarantees quality. In addition, scandals have recently continued due to lack of knowledge about clinical research.
In February 2012, we established the Teikyo Academic Research Center (TARC) with the aim of supporting clinical research from the early stages, and started activities related to clinical research support.
This course is set up as a course of the School of Medicine that fully supports TARC for the purpose of supporting clinical research from an academic point of view and returning the results to society. As a result, TARC can receive supports from many industries.
Course representative | Tamio Teramoto additional post Professor |
---|---|
Installation period | April 1, 2018-March 31, 2023 |
Donor | Regional Medical Research Fund |
Main course contents |
|
As the aging of the population progresses, the number of people receiving nursing care and long-term care is increasing year by year. Rehabilitators are vulnerable to health hazards from environmental fungi and indigenous fungi .Therefore, appropriate fungal disease management is required. Similarly, appropriate management is required for care providers who are always in contact with the care recipient. We hope that the research in this endowed course will advance the analysis of the current state of fungal-related health disorders and contribute to the establishment of an appropriate fungal disease management methodology.
Course representative | Koichi Makimura additional post Professor |
---|---|
Research member | Muhammad Mahdi Specially Appointed Assistant Professor Specially Appointed Researcher |
Installation period | April 1, 2019-March 31, 2024 |
Donor | Social welfare corporation Hirakata nursery school |
Main course contents |
|
In cancer treatment, especially in brain tumors, the development of minimally invasive medical technology is required. In the sera nostics course, we are conducting basic research on diagnosis and treatment (ceranostics) by combining ultrasonic responsive bubble preparations and ultrasonic waves. We are aiming to build a new transcranial treatment system that examines the vascular structure of the target tissue and delivers the drug simply by irradiating the skull with ultrasonic waves. Part of the research is being carried out in collaboration with Faculty of Pharma-Science, Drug Delivery Laboratory (Professor Ryo Suzuki, Assistant Professor Daiki Omata) and Teikyo Cancer Center (Head of Center, Nobuhiko Seki).
Course representative | Kazuo Maruyama Specially Appointed Professor |
---|---|
Research member | Sanae Oda Specially Appointed Researcher |
Installation period | April 1, 2019-March 31, 2023 |
Donor | Welcia Yakkyoku Co., Ltd. |
Main course contents |
|
In order to provide a full range of medical care to patients, it is important to have "pharmaceutical cooperation" in which pharmacists at hospitals and pharmacies share information. If the cooperation between the two is good, not only the safety management of the drug taken by the patient but also the pathological condition management will be effectively performed, which will lead to the improvement of QOL. However, although its importance is emphasized, it is not fully functioning at present.
In this course, we will start activities for the purpose of conducting lifelong education, training and research with practical work for the purpose of cooperation between Teikyo University Hospital and regional pharmacies.
Course representative | Nobuhiro Yasuno Specially Appointed Professor |
---|---|
Installation period | April 1, 2019-March 31, 2024 |
Donor | Ein Holdings Inc. |
Main course contents |
|
Silkworm is an industrial insect whose lineage and breeding method have been established in the long history of sericulture in Japan. In addition to silk production, silkworm has been used as a recombinant protein production plant. This course proposes silkworm as an alternative to experimental animals such as mice in drug development, and has been independently developed by the Medical and Fungal Research Center of our university. The purpose is to further expand this field and establish it as a new academic field. Silkworm is effective not only for pharmaceutical products but also for evaluation of food seeds, and it is possible to search for foodstuffs such as lactic acid bacteria that promote innate immunity. In this course, we aim to develop not only pharmaceutical products but also food seeds.
Course representative | Specially Appointed Professor Seki Mizuhisa |
---|---|
Installation period | April 1, 2021 to March 31, 2023 |
Donor | Genome Drug Discovery Research Institute Co., Ltd. |
Main course contents |
|